2012
DOI: 10.1016/j.fitote.2012.03.010
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics and tissue distribution study of scoparone in rats by ultraperformance liquid-chromatography with tandem high-definition mass spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
23
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
8
1

Relationship

5
4

Authors

Journals

citations
Cited by 37 publications
(25 citation statements)
references
References 19 publications
2
23
0
Order By: Relevance
“…Evidence shows that scoparone could yield potential benefits in the treatment and prevention for liver diseases, such as a potent inhibitor of hepatic fibrosis induced by carbon tetrachloride Yin et al, 2012;Zhang et al, 2011 and. All these results suggest that it may be a potent drug candidate for further study and up to now, its therapeutic mechanism has still been completely unclear.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Evidence shows that scoparone could yield potential benefits in the treatment and prevention for liver diseases, such as a potent inhibitor of hepatic fibrosis induced by carbon tetrachloride Yin et al, 2012;Zhang et al, 2011 and. All these results suggest that it may be a potent drug candidate for further study and up to now, its therapeutic mechanism has still been completely unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Yinchenhao (Artemisia annua L.) is one of the most popular traditional Chinese medicinal plants for treatment of liver disorders Wang et al, 2013;Zhang et al, 2011). It can be used clinically to treat liver fibrosis, cholestasis, hepatitis C, and cholestatic diseases (Yin et al, 2012). Interestingly, scoparone (Fig.…”
mentioning
confidence: 99%
“…It found that D was distributed and eliminated rapidly. Tissue distribution showed the highest level was observed in liver, followed by the kidney and spleen; the lower level appeared in the muscle, thyroid, and adrenal [20]. It was not detected in the brain which indicated that D does not cross the blood-brain barrier after oral administration.…”
Section: Pharmacokinetic Studiesmentioning
confidence: 99%
“…UHPLC-MS pharmacokinetic studies of TCMs have been performed by many groups (Yang et al 2012; Li et al 2012; Qiu et al 2011;Yin et al 2012; Gan et al 2012; Xiong et al 2010; Wang, et al 2011; Sun et al 2012). A pharmaco-metabolomics study to explore the therapeutic basis and to clarify the mechanism of traditional Chinese medicine by UHPLC-MS has also been reported (Sun et al 2013; Zhang et al 2011).…”
Section: Introductionmentioning
confidence: 99%